WHO ICTRP trial
A multicenter, double-blind, randomized, active comparator, forced-titration…
EUCTR2005-003270-14-DE · EU Clinical Trials Register · Not Recruiting
Key facts
| Trial ID | EUCTR2005-003270-14-DE |
|---|---|
| Public title | A multicenter, double-blind, randomized, active comparator, forced-titration study to compare the efficacy and safety of the combination of 145 mg fenofibrate and 20 or 40 mg simvastatin with 40 mg simvastatin monotherapy in patients with mixed dyslipidemia at risk of cardiovascular disease not adequately controlled by 20 mg simvastatin alone - N/A |
| Scientific title | A multicenter, double-blind, randomized, active comparator, forced-titration study to compare the efficacy and safety of the combination of 145 mg fenofibrate and 20 or 40 mg simvastatin with 40 mg simvastatin monotherapy in patients with mixed dyslipidemia at risk of cardiovascular disease not… |
| Primary sponsor | FOURNIER Laboratories Ireland Ltd |
| Registry | EU Clinical Trials Register |
| Recruitment status | Not Recruiting |
| Study type | Interventional clinical trial of medicinal product |
| Countries | Hungary;Czech Republic;Germany |
| Conditions | Study in patients with mixed dyslipidemia at risk of cardiovascular disease not adequately controlled by 20 mg simvastatin alone |
| Interventions | Product Name: simvastatin 20 mg Product Code: N/A Pharmaceutical Form: Film-coated tablet INN or Proposed INN: simvastatin CAS Number: 79902-63-9 Current Sponsor code: N/A Other descriptive name: N/A Concentration unit: mg milligram(s)… |
| Registration date | Oct 10, 2005 |
| Target size | 3900 |
| Secondary IDs | C LF0242780-01 05 01;N/A |
| Registry page | clinicaltrialsregister.eu |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: